Mark B. Orringer mainly focuses on Surgery, Esophagus, Esophagectomy, Adenocarcinoma and Esophageal disease. His work is dedicated to discovering how Esophagus, Carcinoma are connected with Radiation therapy, Fluorouracil and Gastroenterology and other disciplines. He has researched Esophagectomy in several fields, including Stomach surgery, Survival analysis and Atelectasis.
His research integrates issues of Molecular biology, Cancer research, Lung cancer and Gene expression profiling in his study of Adenocarcinoma. His Lung cancer research is multidisciplinary, incorporating perspectives in Respiratory disease, Lung and Genetics. His studies deal with areas such as Achalasia, Esophageal cancer and Pathology as well as Esophageal disease.
Mark B. Orringer mainly investigates Surgery, Esophagus, Esophagectomy, Adenocarcinoma and Internal medicine. His research in Surgery intersects with topics in Reflux and General surgery. His Esophagus research integrates issues from Stomach and Carcinoma.
Mark B. Orringer interconnects Retrospective cohort study, Chylothorax, Achalasia and Perforation in the investigation of issues within Esophagectomy. His Adenocarcinoma study combines topics in areas such as Molecular biology, Cancer research and Lung cancer, Pathology. His work on Cancer as part of general Internal medicine study is frequently linked to In patient, bridging the gap between disciplines.
Internal medicine, Surgery, Esophagectomy, Esophageal cancer and Oncology are his primary areas of study. In the subject of general Internal medicine, his work in Adenocarcinoma, Cancer and Lung cancer is often linked to In patient, thereby combining diverse domains of study. His work carried out in the field of Adenocarcinoma brings together such families of science as Esophagus, Cancer research and Carcinoma, Pathology.
His Lung cancer research is multidisciplinary, incorporating elements of Vein, Radiology and Circulating tumor cell. Mark B. Orringer combines subjects such as Transhiatal esophagectomy, Atrial fibrillation and General surgery with his study of Surgery. His study on Esophagectomy also encompasses disciplines like
Mark B. Orringer spends much of his time researching Adenocarcinoma, Cancer, Esophagectomy, Surgery and Carcinoma. His Adenocarcinoma study combines topics from a wide range of disciplines, such as Cancer research, Selumetinib, Akt/PKB signaling pathway, Immunology and Pathology. His study on Cancer is covered under Internal medicine.
Esophagectomy is a subfield of Esophageal cancer that Mark B. Orringer tackles. His work in Esophageal cancer covers topics such as Esophagus which are related to areas like Esophagogastric junction and Gastroenterology. As part of one scientific family, Mark B. Orringer deals mainly with the area of Surgery, narrowing it down to issues related to the Multivariate analysis, and often Malignancy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding;Gad Getz;David A. Wheeler;Elaine R. Mardis.
Nature (2008)
Gene-expression profiles predict survival of patients with lung adenocarcinoma
David G. Beer;Sharon L.R. Kardia;Chiang Ching Huang;Thomas J. Giordano.
Nature Medicine (2002)
Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma
Susan G. Urba;Mark B. Orringer;Andrew Turrisi;Mark Iannettoni.
Journal of Clinical Oncology (2001)
Characterizing the cancer genome in lung adenocarcinoma
Barbara A. Weir;Barbara A. Weir;Michele S. Woo;Gad Getz;Sven Perner;Sven Perner.
Nature (2007)
Discordant Protein and mRNA Expression in Lung Adenocarcinomas
Guoan Chen;Tarek G. Gharib;Chiang Ching Huang;Jeremy M.G. Taylor.
Molecular & Cellular Proteomics (2002)
Transhiatal esophagectomy: clinical experience and refinements.
Mark B. Orringer;Becky Marshall;Mark D. Iannettoni.
Annals of Surgery (1999)
Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology
Jaffer A. Ajani;Thomas A. D'Amico;Khaldoun Almhanna;David J. Bentrem.
Journal of The National Comprehensive Cancer Network (2016)
Esophagectomy without thoracotomy.
Mark B. Orringer;Herbert Sloan.
The Journal of Thoracic and Cardiovascular Surgery (1978)
Two Thousand Transhiatal Esophagectomies Changing Trends, Lessons Learned
Mark B. Orringer;Becky Marshall;Andrew C. Chang;Julia Lee.
Annals of Surgery (2007)
Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.
Richard L. Wahl;Leslie E. Quint;Robert L. Greenough;Charles R. Meyer.
Radiology (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Michigan–Ann Arbor
University of Michigan–Ann Arbor
Duke University
The University of Texas MD Anderson Cancer Center
University of Michigan–Ann Arbor
University of Michigan–Ann Arbor
University of Michigan–Ann Arbor
The University of Texas MD Anderson Cancer Center
Boston Children's Hospital
The University of Texas MD Anderson Cancer Center
Fujian Medical University
Lehigh University
McGill University
University of Melbourne
University of Bayreuth
Case Western Reserve University
University of Ottawa
KU Leuven
University of Wisconsin–Madison
Sapienza University of Rome
University of Wisconsin–Milwaukee
Université Paris Cité
Cleveland Clinic Lerner College of Medicine
University of Birmingham
University of Hong Kong
Kennedy Krieger Institute